The Trump administration has moved forward with a partial ban on some e-cigarette flavors in an attempt to limit the widespread usage of the products with young people. However, the FDA described the policy priorities not as a ban, as the agency has accepted and begun reviewing applications for flavored e-cigarette products.

Amyloid plaques have long been the target of Alzheimer’s-focused research, but a new study suggests it may be time to prioritize tau imaging instead.

One New York City woman received the shock of a lifetime when her surprise medical bill to treat a cold and sore throat toped $25,000.

Affidea, a European healthcare provider with more than 240 locations, announced it is now implementing Subtle Medical’s SubtlePET solution in its PET-CT center in Italy.

The tech company has been working alongside Northwestern University and several U.K. institutions for years to develop the model.

The Silicon Valley company's DeepMind AI beat out six expert readers and with further clinical testing could change the face of early breast cancer detection.

Drug prices are on the move upward once again in 2020, according to new data from 3 Axis Advisors.

Microbot Medical, a Hingham, Massachusetts-based healthcare technology company, has announced plans to debut a fully disposable robotic system to be used during neurovascular, cardiovascular and peripheral vascular procedures.

Deep-learning based AI models can identify breast cancer more accurately than radiologists, according to new research published in Nature. What does this mean for the future of cancer detection?

Hospital acquisitions may have a negative impact on the quality of patient care, according to new findings published in the New England Journal of Medicine. The study results may help answer the question of how mergers and acquisitions impact patients and quality of care.